BioReliance by SAFC is looking forward to the Phacilitate Washington Vaccine Forum next week. We will be onsite from January 30th to February 1st at the Grand Hyatt in Washington, DC, and hope you can join us at Booth 51, where we will be available to talk about the latest trends in vaccine testing technology.
The event itself is recognized as a key meeting point for senior level industry and public sector decision makers to gather and drive strategy and development of novel prophylactic and therapeutic vaccines for developed markets. This is the 11th edition of the North American Vaccine Forums, and this year will again feature key players discussing the most relevant global public health and industry issues, including:
— vaccine R&D
— policy and regulation
— funding and business development
— risk strategies and validation
— clinical translation
— research and progress for the scientific industry
Phacilitate will also feature a vaccine biotech showcase with a glimpse into the future from cutting edge biotechs, as well as a look into the next stage of cancer treatment. Attendees of the event can also benefit from unlimited access to co-located conferences Protein Therapeutics Forum and the Cell & Gene Therapy Forum.
To learn more about attending Phacilitate, please click here
To learn more about the BioReliance by SAFC service offering, please click here. To read a recent regulatory update by BioReliance, please click here and note that we will continue to offer updated regulatory reviews on a quarterly basis.
To learn more about SAFC, please click here.